Alexandre Sostelly

Alexandre SOSTELLY is a highly experienced professional in clinical pharmacology and development, currently serving as Senior Director, Clinical Development Leader at Alnylam Pharmaceuticals since December 2022, overseeing CNS programs in early phases. Previously held roles include Senior Director in Clinical Pharmacology and Pharmacometrics, with oversight of CNS and Oncology portfolios, and Senior Principal Scientist at Roche, where important projects included leading clinical pharmacology teams for various therapeutic areas. Prior experiences at Merck Group also included significant contributions as a Modeling and Simulation Project Representative and Senior PK/PD Scientist. SOSTELLY's academic credentials include a Ph.D. in Pharmacology from Université Claude Bernard Lyon 1, along with a Master’s in Pharmaceutical Medicine from King's College London, and extensive training in pharmacometrics and oncology research during early academic career stages.